Why Believing Donald Trump Will Be the GOP Nominee Is Delusional
![U.S. Republican presidential candidate Donald Trump listens to a question at the Family Leadership Summit in Ames](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/media/07202015_Donald_Trump.jpg?itok=96rtzaWp)
Despite his commanding lead at this early stage among GOP candidates, the 2016 nomination is anyone’s game.
It is risky to put too much stock in the latest findings, including the NBC/Wall Street Journal poll released Sunday. That’s because the national telephone survey of 1,000 adults included only 252 registered voters who said they would vote for a Republican, and the poll has a margin of error of plus or minus 6.17 points.
Related: Why Jeb Bush’s Pragmatic Immigration Plan Has No Chance of Passing in the House
There are plenty of downsides to Trump’s candidacy – including his threat to mount a third-party campaign if he is denied the Republican nomination -- which has alarmed GOP leaders who are looking down the road to the general election.
Trump has the highest negatives of any of the top tier candidates, and a majority of Americans in the survey said they think Trump is hurting the Republican Party. Not surprisingly, the vast majority of Democrats interviewed said Trump was harming his party’s image, but nearly half the Republicans interviewed said the same thing.
Political analyst Nate Silver notes that Trump ranks just 13th in overall favorability among Republicans in a series of national polls. “If you’re going to imply that a candidate is popular based on their receiving 20 percent of the vote, you ought to consider what the other 80 percent thinks about him,” Silver wrote recently in his FiveThirtyEight blog. “Most Republicans who don’t plan to vote for Trump are skeptical of him instead.”
Related: Donald Trump Just Showed Why His Campaign Is Doomed
What’s more, about three in four Latinos said they have a negative view of Trump – and that more than half consider his comments about lawless Mexican immigrants to be racist or highly inappropriate, according to a separate NBC News/Wall Street Journal Telemundo poll released today.
The survey of 250 Hispanic-American voters revealed widespread hostility towards Trump, with only 13 percent saying they have a positive view of him.
The Republican presidential frontrunner has said repeatedly that many Latino voters “love” and support him, and that he would win the majority of that vote if he ends up as his party’s nominee. There is little evidence in this poll to suggest Trump is dealing with reality.
Top Reads from The Fiscal Times:
- Clinton Tries to Change the Narrative with First Two Campaign Ads
- Super PAC or Not-so-Super PAC? The Difference Between Jeb and Bernie
- States Are Finally Overcoming the Fiscal Headwinds
Tax Refunds Rebound
![](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/media/120916_tax-returns-taxes.jpg?itok=BnLMqpxX)
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
![](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/articles/06052012_US_debt_article.jpg?itok=HsRxqLe6)
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
![Client Sanon has her finger pricked for a blood sugar test in the Family Van in Boston](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/media/05082015_Diabetes_Test.jpg?itok=zqK6NepO)
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
![Lumberton, North Carolina An aerial view shows a neighborhood that was flooded after Hurricane Matthew in Lumberton, North Carolina](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/slides/091116_Hurricane_Matthew2.jpg?itok=ZBjFCrcX)
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
![A growing number of patients are being denied access to newer oral chemotherapy drugs for cancer pills with annual price tags of more than $75,000.](https://cdn.thefiscaltimes.com/sites/default/assets/styles/article_hero/public/articles/03222010_Pills_article.jpg?itok=QwQLvxAP)
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.